Biocon up by 8 per cent, to consider bonus issue
DSIJ Intelligence / 25 Apr 2017
As on April 25, 2017, the stock of Biocon was trading at Rs 1155.95, increased by 8.48 per cent at 10:25 hrs IST on the BSE.
Biocon, one of the most prominent drug producers in India, in its meeting scheduled for taking on records and approving the financial results of FY17, is also likely to consider and recommend issuance of bonus shares and final dividend for the concluding FY17 on April 27, 2017.
However the trading window for the company's designated employees, and their immediate relatives to deal in company's equity shares will remain closed from April 1, 2017 till April 29, 2017.
As on April 25, 2017, the stock of Biocon was trading at Rs 1155.95, increased by 8.48 per cent at 10:25 hrs IST on the BSE.
Recently, the pharma major also tied up with a Japanese drug firm, Eisai Pharma, to market its anti-ulcer drug, rabeprazole, in India.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.